ISO 14971
What is ISO 14971: Medical Device Risk Management
ISO 14971 is the internationally recognized standard for applying risk management to medical devices. ISO 14971:2019 specifies a process by which medical device manufacturers can identify hazards, estimate and evaluate risks, implement risk controls, and monitor the effectiveness of those controls throughout the medical device lifecycle.
ISO 14971 risk management for medical devices applies throughout the product lifecycle, from initial design and development through manufacturing, commercialization, and post-market activities.
A structured ISO 14971 process helps organizations connect risk management with design controls, quality processes, production activities, complaint handling, CAPA, and post-market surveillance.
What Is ISO 14971?
ISO 14971 is the international standard for medical device risk management. The standard provides a systematic framework for identifying hazards associated with medical devices, evaluating and controlling associated risks, and monitoring risks throughout the product lifecycle.
The current edition is ISO 14971:2019, titled Medical devices — Application of risk management to medical devices.
The standard applies to organizations involved in the design, development, production, and lifecycle management of medical devices.
ISO 14971 risk management activities may include:
- Risk management planning
- Hazard identification
- Risk analysis
- Risk estimation
- Risk evaluation
- Risk control
- Residual risk evaluation
- Benefit-risk analysis
- Production and post-production monitoring
- Risk management reporting
- Risk management documentation
The goal is not to eliminate every possible risk. Instead, manufacturers use a structured process to identify risks, evaluate their significance, implement appropriate controls, and determine whether remaining risks are acceptable.
ISO 14971: Simplified
ISO 14971 provides a structured way for medical device manufacturers to answer three fundamental questions:
What could go wrong?
Organizations identify hazards and reasonably foreseeable sequences of events that could lead to harm.
How serious and likely is the potential harm?
Manufacturers analyze and evaluate risks based on factors such as the severity of harm and the probability of occurrence.
What can we do about it?
Organizations implement risk controls to reduce risks and then evaluate whether the remaining residual risks are acceptable.
Risk management does not end when a product is released. Manufacturers should continue monitoring information from complaints, production, suppliers, service activities, and post-market experience to determine whether new risks have emerged or existing risks have changed.
Why ISO 14971 Matters in Medical Devices
Medical devices can introduce risks to patients, users, healthcare professionals, and others throughout their lifecycle. Effective risk management helps manufacturers identify potential hazards before they result in harm and provides a structured framework for reducing those risks.
An effective ISO 14971 medical device risk management process helps organizations:
Protect Patient and User Safety
Risk management helps manufacturers identify hazards and evaluate how medical devices could potentially cause harm.
Early identification of risks allows organizations to implement appropriate controls during design and development, when changes are generally easier and less costly to make.
Improve Product Quality
Risk management provides objective information that can influence product requirements, design decisions, manufacturing controls, labeling, and other quality activities.
Integrating risk considerations throughout development can help organizations prevent design-related problems and improve overall product quality.
Support Regulatory Compliance
Risk management is an important component of medical device regulatory frameworks and quality management systems.
A documented ISO 14971 compliance process provides evidence that an organization has systematically identified, evaluated, controlled, and monitored risks associated with its medical devices.
Improve Design Decisions
Risk analysis provides engineering and product development teams with information that can influence design requirements and risk controls.
Connecting risk assessments to design inputs, design outputs, verification, validation, and design changes helps organizations make more informed development decisions.
Establish Consistent Risk Evaluation
A standardized ISO 14971 risk assessment process provides consistent methods for evaluating risks across products and development projects.
This helps cross-functional teams use common terminology, criteria, and documentation when making risk-based decisions.
Reduce Development Risk
Identifying hazards early can help manufacturers address potential problems before they become expensive design changes, testing failures, manufacturing problems, or post-market issues.
Strengthen Traceability
Risk management records can be connected to design requirements, risk controls, verification activities, complaints, CAPAs, and changes.
This traceability helps demonstrate how identified risks were evaluated and how controls were implemented and verified.
Support Post-Market Monitoring
Risk management continues after commercialization.
Information from complaints, adverse events, production data, service activities, supplier issues, and other post-market sources can reveal new hazards or changes in previously identified risks.
Support Continuous Improvement
Risk information can help organizations identify opportunities to improve product designs, manufacturing processes, quality controls, and post-market activities.
ISO 14971 Risk Management Process
The ISO 14971 risk management process provides a systematic approach to managing medical device risks throughout the product lifecycle.
While organizations may structure their workflows differently, a typical process includes:
Risk Management Planning
Organizations establish a risk management plan that defines the scope, responsibilities, methods, criteria, and activities that will be used to manage risks for a medical device.
The plan may define:
- Applicable risk management activities
- Roles and responsibilities
- Risk acceptability criteria
- Risk analysis methods
- Risk control methods
- Verification requirements
- Production and post-production monitoring activities
- Requirements for maintaining the risk management file
Risk Analysis
ISO 14971 risk analysis involves identifying hazards and evaluating the risks associated with those hazards.
Risk analysis may include:
- Intended use
- Reasonably foreseeable misuse
- Hazard identification
- Sequences of events
- Hazardous situations
- Potential harms
- Probability of occurrence
- Severity of harm
The purpose is to develop a clear understanding of how a medical device could potentially cause harm.
Risk Evaluation
After risks are analyzed, organizations evaluate them against predefined risk acceptability criteria.
ISO 14971 risk evaluation helps determine which risks require additional risk control measures and which risks may be considered acceptable based on the organization’s established criteria.
Risk Control
When risk reduction is required, manufacturers implement appropriate ISO 14971 risk control measures.
Risk controls may include:
- Inherently safe design
- Protective measures
- Alarms or warnings
- Labeling
- Instructions for use
- Manufacturing controls
- Inspection and testing
Risk controls should be verified to demonstrate that they have been implemented effectively and achieve their intended purpose.
Residual Risk Evaluation
After risk controls are implemented, organizations evaluate the remaining ISO 14971 residual risk.
Residual risk is the risk that remains after risk control measures have been implemented.
Organizations should determine whether residual risks meet established acceptability criteria and whether additional evaluation or communication is necessary.
Benefit-Risk Analysis
In some situations, a residual risk may not meet predefined acceptability criteria.
An ISO 14971 benefit-risk analysis may be used to determine whether the benefits of using the medical device outweigh the remaining risk, based on appropriate evidence.
Production and Post-Production Information
Risk management continues after the device reaches the market.
Organizations should collect and evaluate relevant information from:
- Complaints
- Adverse events
- CAPA
- Nonconformances
- Supplier issues
- Production data
- Service activities
- Post-market surveillance
- Regulatory information
New information may require manufacturers to revisit previous risk assessments or implement additional risk controls.
ISO 14971 Requirements
The ISO 14971 requirements establish a systematic risk management process that manufacturers can apply throughout the medical device lifecycle.
Key requirements include:
- Establishing a risk management process
- Defining responsibilities and authorities
- Developing a risk management plan
- Identifying hazards
- Performing risk analysis
- Estimating and evaluating risks
- Establishing risk control measures
- Verifying implementation of risk controls
- Evaluating residual risks
- Performing benefit-risk analysis when appropriate
- Maintaining risk management documentation
- Establishing a risk management report
- Collecting production and post-production information
- Reviewing new risk information throughout the lifecycle
The standard emphasizes that risk management should be an ongoing process rather than a one-time activity performed only during product development.
ISO 14971 and ISO 13485
ISO 14971 and ISO 13485 serve different but complementary purposes within a medical device Quality Management System. ISO 13485 establishes requirements for the overall QMS, while ISO 14971 provides a structured framework for managing risks associated with medical devices.
Area
ISO 14971 |
ISO 13485 |
Primary Focus
Medical device risk management
Medical device Quality Management System |
Purpose
Establishes a systematic process for identifying, evaluating, controlling, and monitoring medical device risks |
Establishes requirements for a QMS that consistently supports medical device quality and regulatory compliance |
Scope
Focuses specifically on risks associated with medical devices and their lifecycle |
Covers the broader quality system and processes used to design, manufacture, distribute, and maintain medical devices |
Risk Management
Provides the primary framework for medical device risk management |
Requires organizations to incorporate appropriate risk-based processes throughout the QMS |
Product Safety
Helps identify hazards and reduce risks associated with device use |
Provides the quality system framework that supports consistent product development and manufacturing |
Design Controls
Risk management activities influence design requirements and risk controls |
Establishes QMS requirements supporting design and development processes |
Documentation
Includes risk management plans, risk assessments, risk controls, residual risk evaluations, and risk management files |
Includes controlled documents, procedures, quality records, and other QMS documentation |
CAPA
CAPA findings may provide information that requires risk reassessment |
Establishes requirements for corrective and preventive action processes |
Change Control
Changes may require existing risks and controls to be reevaluated |
Provides QMS processes for controlling changes that could affect product or process quality |
Supplier Quality
Supplier issues may introduce or change medical device risks |
Establishes requirements for controlling and evaluating suppliers |
Complaint Handling
Complaint information can provide new or changed risk information |
Establishes processes for receiving, evaluating, and managing complaints |
Post-Market Activites
Requires production and post-production information to be considered within risk management |
Provides the broader QMS framework for post-market and feedback processes |
Relationship
Provides the medical device risk management framework |
Provides the broader Quality Management System in which risk management activities can operate |
Area
ISO 14971 |
ISO 13485 |
Primary Focus
Medical device risk management
Medical device Quality Management System |
Purpose
Establishes a systematic process for identifying, evaluating, controlling, and monitoring medical device risks |
Establishes requirements for a QMS that consistently supports medical device quality and regulatory compliance |
Scope
Focuses specifically on risks associated with medical devices and their lifecycle |
Covers the broader quality system and processes used to design, manufacture, distribute, and maintain medical devices |
Risk Management
Provides the primary framework for medical device risk management |
Requires organizations to incorporate appropriate risk-based processes throughout the QMS |
Product Safety
Helps identify hazards and reduce risks associated with device use |
Provides the quality system framework that supports consistent product development and manufacturing |
Design Controls
Risk management activities influence design requirements and risk controls |
Establishes QMS requirements supporting design and development processes |
Documentation
Includes risk management plans, risk assessments, risk controls, residual risk evaluations, and risk management files |
Includes controlled documents, procedures, quality records, and other QMS documentation |
CAPA
CAPA findings may provide information that requires risk reassessment |
Establishes requirements for corrective and preventive action processes |
Change Control
Changes may require existing risks and controls to be reevaluated |
Provides QMS processes for controlling changes that could affect product or process quality |
Supplier Quality
Supplier issues may introduce or change medical device risks |
Establishes requirements for controlling and evaluating suppliers |
Complaint Handling
Complaint information can provide new or changed risk information |
Establishes processes for receiving, evaluating, and managing complaints |
Post-Market Activites
Requires production and post-production information to be considered within risk management |
Provides the broader QMS framework for post-market and feedback processes |
Relationship
Provides the medical device risk management framework |
Provides the broader Quality Management System in which risk management activities can operate |
What does the QMSR change for medical device manufacturers?
The transition from QSR to QMSR brings FDA quality management requirements into closer alignment with ISO 13485:2016. Rather than maintaining a separate FDA quality system framework, the QMSR incorporates ISO 13485 by reference while retaining certain FDA-specific requirements. Manufacturers should therefore evaluate their existing QMS against the current QMSR requirements and ensure that documentation, processes, and records continue to meet applicable FDA expectations.
How ISO 14971 and ISO 13485 Work Together
ISO 14971 and ISO 13485 are complementary standards rather than competing standards. A medical device manufacturer can use ISO 13485 to establish and maintain its overall Quality Management System while using ISO 14971 to manage risks associated with its medical devices.
For example, during product development, an organization may use its ISO 13485-compliant QMS to establish design control processes while applying the ISO 14971 risk management process to identify hazards, assess risks, establish risk controls, and evaluate residual risks.
Risk management can also connect to quality processes throughout the product lifecycle:
- Design Controls: Risk assessments can influence design inputs, design outputs, verification, validation, and design changes.
- CAPA: Corrective actions may identify new risks or provide information requiring existing risks to be reevaluated.
- Change Control: Product, process, or supplier changes may affect existing risk assessments or risk controls.
- Supplier Quality: Supplier issues can introduce new risks or increase existing product and process risks.
- Complaint Handling: Complaint trends can provide post-market information that affects risk evaluations.
- Quality Events: Nonconformances and other quality events may provide information that requires risk assessment.
- Post-Market Surveillance: Production and post-production information can be used to identify emerging risks and evaluate the effectiveness of existing controls.
ISO 14971 vs. ISO 13485: In Simple Terms
The easiest way to understand the relationship is:
ISO 13485 = the Quality Management System
ISO 14971 = the medical device risk management process
ISO 13485 provides the broader framework for managing quality across the organization, while ISO 14971 provides a structured methodology for identifying and controlling risks associated with medical devices.
When these processes are connected, organizations can maintain better traceability between risks, design controls, quality events, CAPAs, complaints, supplier issues, and changes throughout the medical device lifecycle.
This integrated approach can help medical device manufacturers demonstrate that risk management is not a standalone activity, but an important part of an effective and compliant Quality Management System.
ISO 14971 vs. Quality Risk Management
Although ISO 14971 medical device risk management and quality risk management are closely related, they are not exactly the same. ISO 14971 provides a specific framework for managing risks associated with medical devices, while quality risk management is a broader approach that can be applied to products, processes, suppliers, manufacturing operations, and the Quality Management System itself.
Area
ISO 14971 Risk Management |
Quality Risk Management |
Primary Focus
Risks associated with the safety and performance of medical devices |
Risks that may affect product quality, processes, compliance, suppliers, or operations |
Scope
Focuses specifically on medical devices throughout their lifecycle |
Can apply across the broader Quality Management System and business operations |
Risk Identification
Identifies hazards, hazardous situations, sequences of events, and potential harms |
Identifies potential failures, quality issues, process risks, compliance risks, and operational risks |
Risk Assessment
Evaluates medical device risks using defined criteria for severity, probability, and risk acceptability |
Evaluates risks based on their potential impact on quality, compliance, processes, products, or business operations |
Risk Controls
Establishes controls to reduce medical device risks to acceptable levels |
Establishes controls to reduce or manage broader quality and operational risks |
Residual Risk
Requires evaluation of risks remaining after risk controls are implemented |
May evaluate remaining risk depending on the organization’s risk management methodology |
Benefit-Risk Analysis
May be used when residual risk remains unacceptable and additional risk control is not reasonably practicable |
May be considered as part of broader risk-based decision making, depending on the process |
Documentaion
Maintains documented risk management activities, including the risk management plan, risk assessments, risk controls, and risk management file |
Documentation varies depending on the quality process and type of risk being evaluated |
Lifecycle
Applies throughout the medical device lifecycle, including production and post-production activities |
May apply throughout the lifecycle of quality processes, products, suppliers, and operations |
Examples
Device failure, electrical hazard, software-related hazard, usability-related harm |
Supplier failure, process deviation, CAPA risk, audit finding, manufacturing disruption |
Common Applications
Design Controls, product development, verification, validation, post-market surveillance |
CAPA, supplier quality, change control, audits, complaints, quality events, manufacturing |
Primary Standard
ISO 14971 |
May be incorporated into an organization’s broader QMS and risk-based processes |
Area
ISO 14971 Risk Management |
Quality Risk Management |
Primary Focus
Risks associated with the safety and performance of medical devices |
Risks that may affect product quality, processes, compliance, suppliers, or operations |
Scope
Focuses specifically on medical devices throughout their lifecycle |
Can apply across the broader Quality Management System and business operations |
Risk Identification
Identifies hazards, hazardous situations, sequences of events, and potential harms |
Identifies potential failures, quality issues, process risks, compliance risks, and operational risks |
Risk Assessment
Evaluates medical device risks using defined criteria for severity, probability, and risk acceptability |
Evaluates risks based on their potential impact on quality, compliance, processes, products, or business operations |
Risk Controls
Establishes controls to reduce medical device risks to acceptable levels |
Establishes controls to reduce or manage broader quality and operational risks |
Residual Risk
Requires evaluation of risks remaining after risk controls are implemented |
May evaluate remaining risk depending on the organization’s risk management methodology |
Benefit-Risk Analysis
May be used when residual risk remains unacceptable and additional risk control is not reasonably practicable |
May be considered as part of broader risk-based decision making, depending on the process |
Documentaion
Maintains documented risk management activities, including the risk management plan, risk assessments, risk controls, and risk management file |
Documentation varies depending on the quality process and type of risk being evaluated |
Lifecycle
Applies throughout the medical device lifecycle, including production and post-production activities |
May apply throughout the lifecycle of quality processes, products, suppliers, and operations |
Examples
Device failure, electrical hazard, software-related hazard, usability-related harm |
Supplier failure, process deviation, CAPA risk, audit finding, manufacturing disruption |
Common Applications
Design Controls, product development, verification, validation, post-market surveillance |
CAPA, supplier quality, change control, audits, complaints, quality events, manufacturing |
Primary Standard
ISO 14971 |
May be incorporated into an organization’s broader QMS and risk-based processes |
How ISO 14971 and Quality Risk Management Work Together
Medical device manufacturers do not necessarily need to choose between ISO 14971 risk management and broader quality risk management. The two approaches can work together as complementary components of an effective Quality Management System.
For example, a manufacturer may use ISO 14971 risk management for medical devices to evaluate the safety risks associated with a device while using broader quality risk management processes to evaluate supplier performance, manufacturing processes, CAPA effectiveness, audit findings, or operational risks.
These processes can also be connected. A supplier quality issue, complaint, CAPA, or manufacturing deviation may provide new information that could affect an existing medical device risk assessment.
Integrating risk information across the QMS helps organizations maintain better visibility into how product risks and quality risks interact throughout the medical device lifecycle.
In simple terms: ISO 14971 focuses on medical device risk, while quality risk management takes a broader view of risks that can affect quality, compliance, processes, and operations. Both can play an important role in a comprehensive medical device Quality Management System.
Benefits of ISO 14971 Risk Management
An effective ISO 14971 risk management process provides benefits throughout the medical device lifecycle, from initial product development through manufacturing, commercialization, and post-market activities. By establishing a structured approach to identifying, evaluating, controlling, and monitoring risks, organizations can make more informed decisions while supporting product safety and regulatory compliance.
Better Risk Visibility
Organizations gain a clearer understanding of hazards, hazardous situations, potential harms, and associated risks.
A structured ISO 14971 risk assessment process helps teams identify which risks are most significant and where additional controls or monitoring may be necessary. Centralizing risk information also gives Engineering, Quality, Regulatory, and other stakeholders greater visibility into the overall risk profile of a medical device.
Improved Product Safety
Identifying and controlling risks early can help reduce the likelihood or severity of harm to patients, users, and other individuals who may interact with the device.
Applying risk management throughout product development allows manufacturers to address potential safety concerns through design improvements, protective measures, labeling, and other appropriate controls before the device reaches the market.
Better Design Decisions
Risk information helps engineering and product teams make informed design decisions throughout development.
Connecting ISO 14971 risk management with design inputs, design outputs, verification, validation, and design changes allows teams to consider potential risks when making product decisions. This can help ensure that safety and performance requirements are incorporated into the design from the beginning.
Stronger Regulatory Compliance
Documented risk management activities provide evidence that risks have been systematically identified, evaluated, controlled, and monitored.
Maintaining an appropriate ISO 14971 risk management file can help organizations demonstrate their risk management approach during regulatory submissions, audits, certification activities, and inspections.
Improved Traceability
Risks can be connected to design requirements, risk controls, verification and validation activities, complaints, CAPAs, quality events, and design changes.
Strong traceability helps organizations demonstrate the relationship between identified risks and the actions taken to address them. It also makes it easier to determine how changes or new quality information may affect existing risks.
Reduced Development Risk
Early risk identification can reduce late-stage design changes, unexpected testing failures, and potential compliance issues.
When teams identify and evaluate risks early, they have more opportunities to address them through design changes or other controls before development is complete. This can reduce costly rework and help keep development programs on track.
Improved Risk-Based Decision Making
A structured risk management process gives organizations objective information that can support decisions across product development and quality management.
Risk information can help teams prioritize resources, determine where additional controls are needed, evaluate proposed changes, and focus attention on the risks with the greatest potential impact.
Better Post-Market Monitoring
Production and post-production information can be evaluated to identify emerging risks or changes in existing risks.
Complaints, nonconformances, CAPAs, supplier issues, service information, and post-market surveillance data can provide valuable information about device performance after commercialization. Connecting this information to the risk management process helps organizations determine when existing risks or controls need to be reevaluated.
Stronger Cross-Functional Collaboration
Risk management brings together Engineering, Quality, Regulatory Affairs, Clinical, Manufacturing, and other stakeholders involved in the medical device lifecycle.
A shared approach to ISO 14971 medical device risk management helps teams work from consistent risk criteria and understand how decisions in one area of the organization can affect product risk in another.
Continuous Improvement
Risk information can help organizations identify opportunities to improve products, processes, and quality controls.
As new information becomes available throughout the product lifecycle, organizations can use that information to reassess risks, improve risk controls, update designs, and strengthen manufacturing and quality processes.
Ultimately, ISO 14971 risk management helps medical device manufacturers move from reactive problem-solving toward a proactive approach to product safety and quality. When risk management is integrated with the broader QMS, organizations can maintain stronger traceability, make better risk-based decisions, and more effectively manage risks throughout the medical device lifecycle.
ISO 14971 Best Practices
Leading medical device organizations commonly follow structured ISO 14971 risk management practices to ensure risks are identified, evaluated, controlled, and monitored throughout the medical device lifecycle. Effective risk management should be integrated into product development and the broader Quality Management System rather than treated as a one-time activity.
Establish a Formal Risk Management Process
Organizations should establish a documented risk management process that defines responsibilities, methods, risk acceptability criteria, documentation requirements, and review processes.
A formal process helps ensure that risk management activities are performed consistently across products and development projects and provides a clear framework for demonstrating compliance with ISO 14971 requirements.
Start Risk Management Early
Risk management should begin early in product development rather than waiting until the design is substantially complete.
Early identification of hazards and potential risks allows teams to address safety concerns through design decisions and risk controls before they become more difficult or expensive to correct. Risk management should continue throughout development and the product lifecycle.
Use Cross-Functional Teams
Effective medical device risk management often requires input from multiple functions, including Engineering, Quality, Regulatory Affairs, Clinical, Manufacturing, Usability, and other relevant stakeholders.
Cross-functional participation helps organizations identify a broader range of potential hazards and ensures that risk decisions consider technical, clinical, manufacturing, and regulatory perspectives.
Connect Risk Management to Design Controls
Risk management should be closely connected to the design control process.
Organizations should link identified risks and risk controls to:
- Design Inputs
- Design Outputs
- Design Reviews
- Verification
- Validation
- Design Changes
This connection helps demonstrate how identified risks influenced product requirements and design decisions and how risk controls were subsequently verified.
Maintain Complete Traceability
Organizations should maintain traceability between hazards, risks, risk controls, and supporting evidence.
A strong ISO 14971 risk management process can connect risks to verification results, validation activities, residual risk evaluations, design changes, complaints, CAPAs, and other quality records.
Complete traceability makes it easier to understand the history of a risk and demonstrate how it was addressed.
Define Risk Acceptability Criteria
Organizations should establish clear and consistent criteria for determining whether estimated risks are acceptable.
Defined criteria help teams make objective and repeatable decisions during ISO 14971 risk assessment and reduce the likelihood that similar risks will be evaluated differently across projects.
Risk acceptability criteria should be established as part of the organization’s risk management planning activities.
Verify Risk Controls
Risk controls should not simply be documented—they should be implemented and appropriately verified.
Organizations should maintain evidence demonstrating that risk controls were implemented as intended and that they are effective in reducing the associated risk.
Teams should also consider whether implementing a risk control introduces new hazards or affects other existing risks.
Evaluate Residual Risks
After risk controls have been implemented, organizations should evaluate the remaining residual risk.
Residual risks should be compared against established acceptability criteria, and additional evaluation or benefit-risk analysis may be necessary when risks remain outside established criteria.
Documenting these decisions provides important evidence within the organization’s risk management documentation.
Monitor Production and Post-Production Information
ISO 14971 risk management does not end when a medical device is released.
Organizations should continue evaluating information from:
- Complaints
- Nonconformances
- CAPAs
- Supplier issues
- Production data
- Service activities
- Adverse events
- Post-market surveillance
This information can identify emerging hazards, changes in risk levels, or situations where existing risk controls may need to be reassessed.
Maintain a Complete Risk Management File
Organizations should ensure that risk management documentation remains current, controlled, and traceable throughout the product lifecycle.
The ISO 14971 risk management file may contain or reference risk management plans, hazard analyses, risk assessments, risk controls, verification evidence, residual risk evaluations, benefit-risk analyses, and other supporting documentation.
Maintaining a complete risk management file also helps organizations respond more efficiently to audits and regulatory inspections.
Integrate Risk Management With the QMS
Risk management should be connected to the organization’s broader Quality Management System.
Relevant processes may include:
- Design Controls
- Quality Events
- CAPA
- Complaint Handling
- Change Control
- Supplier Quality
- Document Control
- Post-Market Surveillance
Integrating these processes helps organizations ensure that new quality information is evaluated for potential impact on product risks.
Review Risks When Changes Occur
Risk assessments should be reevaluated when products, processes, suppliers, manufacturing methods, intended uses, or regulatory requirements change.
Design changes, supplier changes, manufacturing deviations, complaints, and CAPAs may all provide information that affects existing risk assessments.
Establishing connections between ISO 14971 risk management and change control helps organizations identify when changes require updates to risk assessments, risk controls, or residual risk evaluations.
Following these practices helps medical device manufacturers establish a proactive and repeatable ISO 14971 medical device risk management process. It also makes it easier to maintain traceability, support regulatory compliance, and demonstrate that risks have been appropriately managed throughout the product lifecycle.
Common ISO 14971 Challenges
Medical device organizations frequently encounter challenges when implementing and maintaining an ISO 14971 risk management process. As products become more complex and organizations manage multiple development programs, keeping risk information complete, current, and connected to the broader QMS can become increasingly difficult.
Incomplete Hazard Identification
Organizations may overlook hazards, reasonably foreseeable misuse, or sequences of events that could lead to hazardous situations and harm.
Incomplete hazard identification can result in risks being underestimated or controls being overlooked. A structured ISO 14971 hazard analysis process helps teams systematically identify potential sources of harm and consider how those hazards may arise throughout the device lifecycle.
Inconsistent Risk Assessments
Different teams or projects may use different criteria, scoring methods, or assumptions when evaluating risk.
Inconsistent ISO 14971 risk assessment practices can make it difficult to compare risks across products and can lead to inconsistent decision-making. Standardized risk criteria and documented assessment methods help ensure that teams evaluate risks using a consistent approach.
Poor Traceability
Risk assessments may become disconnected from design requirements, risk controls, verification activities, design changes, and quality records.
Without strong traceability, organizations may struggle to demonstrate how a particular risk was identified, what controls were implemented, and how those controls were verified. Connecting risk information across the QMS helps create a more complete record of the organization’s risk management process.
Manual Risk Management
Many organizations rely on spreadsheets, shared documents, and other manual tools to manage risk assessments.
As the number of hazards, risks, controls, and product configurations increases, these tools can become difficult to maintain. Manual processes can also make it harder to manage revisions, approvals, relationships between records, and changes to risk information.
Outdated Risk Assessments
Risk information needs to remain current throughout the medical device lifecycle.
Risk assessments may become outdated when products, suppliers, manufacturing processes, software, intended uses, or regulatory requirements change. Organizations should have processes in place to determine when changes require existing risks to be reevaluated or new risks to be assessed.
Incomplete Risk Controls
Organizations may identify risks without adequately documenting how risk control measures were selected, implemented, and verified.
A complete ISO 14971 risk control process should provide evidence that appropriate controls were implemented and that their effectiveness was evaluated. Risk controls should also be reviewed for the possibility of introducing new hazards or affecting existing risks.
Limited Post-Market Integration
Complaint, CAPA, supplier, production, service, and post-market data may not be effectively connected to the risk management process.
This can make it difficult for organizations to identify emerging risks or recognize changes in the frequency or severity of existing risks. Integrating post-market information with risk management helps organizations determine when risk assessments or controls may need to be updated.
Documentation Gaps
Incomplete or inconsistent risk management records can make it difficult to demonstrate compliance during audits, certification activities, or regulatory inspections.
Organizations need to maintain appropriate documentation throughout the lifecycle, including risk assessments, risk controls, residual risk evaluations, approvals, and supporting evidence within the ISO 14971 risk management file.
Lack of Cross-Functional Visibility
Risk management often involves Engineering, Quality, Regulatory Affairs, Clinical, Manufacturing, and other teams.
When these groups manage risk information in separate systems, important information may not be shared effectively. A centralized approach can improve visibility and help ensure that risk-based decisions are understood across functions.
Difficulty Managing Risk Changes
Design changes, manufacturing changes, supplier changes, complaints, and CAPAs can all affect the risk profile of a medical device.
Organizations need to determine whether these changes require new risk assessments, updates to existing controls, or reevaluation of residual risks. Connecting ISO 14971 risk management with change control and other QMS processes can make these relationships easier to manage.
As medical device portfolios and development programs become more complex, maintaining risk management manually becomes increasingly difficult. Medical device risk management software can help organizations centralize risk information, standardize assessments, maintain traceability, and connect ISO 14971 activities with the broader Quality Management System.
ISO 14971 Software for Medical Devices
Modern ISO 14971 software for medical devices can help organizations manage risk management activities through centralized workflows, controlled documentation, automated approvals, and end-to-end traceability. Instead of relying on disconnected spreadsheets and documents, medical device companies can use risk management software to maintain risk information alongside the other quality and design records that support the product lifecycle.
Medical device risk management software can help organizations standardize risk assessment methods, maintain consistent documentation, connect risks to design and quality activities, and provide greater visibility into the current risk profile of a product.
Common capabilities include:
Risk Management Planning
Risk management software can help organizations create and maintain ISO 14971 risk management plans that define the scope of risk activities, responsibilities, risk acceptability criteria, assessment methods, and review requirements.
Centralizing this information helps ensure that teams follow a consistent risk management process across development projects and product updates.
Hazard Analysis
Software can provide structured workflows for documenting hazards, hazardous situations, sequences of events, and potential harms.
Organizations can maintain a centralized record of identified hazards and connect them to the associated risks, controls, and supporting documentation.
Risk Assessment
ISO 14971 risk assessment software can help teams evaluate risks using standardized criteria such as severity and probability of occurrence.
Using consistent assessment methods helps Engineering, Quality, Regulatory, and other stakeholders apply the same risk evaluation approach across products and development projects.
Risk Control
Risk management software can help organizations document risk control measures and connect those controls to the risks they are intended to reduce.
Teams can also track the implementation and verification of controls, helping demonstrate that identified risk reduction measures were appropriately addressed.
Residual Risk Management
After risk controls are implemented, organizations need to evaluate the remaining residual risk.
Software can help teams document residual risk evaluations, determine whether risks meet established acceptability criteria, and maintain evidence supporting those decisions.
Traceability
One of the most important capabilities of ISO 14971 medical device risk management software is maintaining traceability between risk management activities and other product development and quality processes.
Organizations can connect risks to:
- Design Inputs
- Design Outputs
- Verification
- Validation
- Risk Controls
- Design Changes
- CAPA
- Complaints
- Quality Events
- Post-Market Activities
This connected approach makes it easier to understand how a change, complaint, quality event, or corrective action may affect existing product risks.
Risk Management File
Software can help organizations maintain an organized ISO 14971 risk management file by centralizing risk assessments, risk controls, approvals, supporting evidence, and related documentation.
Version control and revision history also help organizations demonstrate how risk information has changed throughout the product lifecycle.
Risk Management Reporting
Organizations can use software to generate risk management reports and supporting documentation for internal reviews, audits, regulatory submissions, and other quality activities.
Reporting capabilities can provide greater visibility into open risks, risk controls, residual risks, and other important risk management information.
Workflow and Approval Management
Automated workflows can route risk assessments, risk controls, reviews, and approvals to the appropriate stakeholders.
This can reduce reliance on email-based approvals and help ensure that required reviews are completed and documented.
Change Impact Assessment
Changes to products, processes, suppliers, or manufacturing activities can introduce new risks or affect existing risks.
Risk management software can help organizations connect change control activities with risk assessments so teams can evaluate whether a proposed change requires updates to existing risk documentation or controls.
QMS Integration
The most effective ISO 14971 software for medical devices does not operate as a standalone risk management tool. Instead, it connects risk management with the broader Quality Management System.
Risk management can be integrated with:
- Design Controls
- Quality Events
- CAPA
- Complaint Handling
- Change Control
- Supplier Quality
- Document Control
- Training Management
- Post-Market Surveillance
This integration helps organizations maintain risk management as an ongoing QMS activity rather than a separate spreadsheet or collection of disconnected documents.
Improve Audit and Inspection Readiness
Maintaining centralized, traceable risk management records can make it easier to demonstrate how risks were identified, evaluated, controlled, and monitored.
During audits and regulatory inspections, teams can more quickly locate risk assessments, approvals, verification evidence, residual risk evaluations, and related quality records.
An integrated approach to ISO 14971 medical device risk management can ultimately help organizations improve traceability, reduce manual administrative work, standardize risk processes, and maintain a clearer connection between product risks and the broader QMS.
How QuickVault Supports ISO 14971 Risk Management
QuickVault helps medical device companies connect risk management with the broader Quality Management System.
Organizations can connect risk-related activities with processes such as:
- Design Controls
- Quality Events
- CAPA
- Change Control
- Complaint Handling
- Supplier Quality
- Document Control
- Training Management
Connecting these processes improves traceability and gives teams greater visibility into how quality issues, design changes, corrective actions, and other QMS activities can affect product risk.
For growing MedTech companies, integrating risk management with the broader QMS can also reduce manual administrative work and make it easier to maintain organized, audit-ready quality records. Book your personalized demo to see how.
Frequently Asked Questions
What is ISO 14971?
ISO 14971 is the international standard for applying risk management to medical devices. It provides a structured process for identifying hazards, evaluating risks, implementing risk controls, evaluating residual risks, and monitoring risk throughout the medical device lifecycle.
What is ISO 14971:2019?
ISO 14971:2019 is the current edition of the ISO 14971 standard for medical device risk management. It specifies requirements for establishing and maintaining a risk management process throughout the lifecycle of a medical device.
What are the ISO 14971 requirements?
ISO 14971 requirements include establishing a risk management process, creating a risk management plan, identifying hazards, performing risk analysis and risk evaluation, implementing risk controls, evaluating residual risks, conducting benefit-risk analysis when appropriate, maintaining a risk management file and report, and monitoring production and post-production information.
What is ISO 14971 risk analysis?
ISO 14971 risk analysis involves identifying hazards, hazardous situations, foreseeable sequences of events, and potential harms associated with a medical device. Organizations then estimate the associated risks using defined criteria.
What is the difference between risk analysis and risk assessment?
Risk analysis focuses on identifying hazards and estimating associated risks. Risk assessment includes both risk analysis and risk evaluation, where estimated risks are compared against defined acceptability criteria.
What is an ISO 14971 risk management file?
The ISO 14971 risk management file contains or references documentation demonstrating that risk management activities have been performed for a medical device. It may include risk analyses, risk evaluations, risk controls, residual risk assessments, and related evidence.
What is residual risk under ISO 14971?
Residual risk is the risk that remains after risk control measures have been implemented. Organizations evaluate residual risks against predefined criteria and determine whether additional actions or benefit-risk analysis are necessary.
What is an ISO 14971 risk management plan?
An ISO 14971 risk management plan defines how risk management activities will be performed for a medical device. It establishes the scope, responsibilities, methods, criteria, and activities used to identify, evaluate, control, and monitor risks.
Does ISO 14971 require a risk management report?
Yes. The standard requires the manufacturer to document a risk management report that provides evidence that the risk management plan has been appropriately implemented and that the results of the risk management process have been reviewed.
How does ISO 14971 relate to ISO 13485?
ISO 14971 focuses specifically on medical device risk management, while ISO 13485 establishes requirements for the broader medical device Quality Management System. Risk management activities should be integrated with applicable QMS processes throughout the medical device lifecycle.